Wahed Invest’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.39M Sell
31,533
-1,263
-4% -$177K 0.57% 32
2025
Q4
$4.03M Sell
32,796
-1,276
-4% -$155K 0.53% 33
2025
Q3
$3.78M Buy
34,072
+216
+0.6% +$24.6K 0.52% 35
2025
Q2
$3.75M Buy
+33,856
New +$3.6M 0.57% 30
2024
Q3
Sell
-29,941
Closed -$2.05M 230
2024
Q2
$2.05M Buy
29,941
+5,485
+22% +$366K 0.41% 45
2024
Q1
$1.79M Buy
24,456
+3,314
+16% +$255K 0.41% 47
2023
Q4
$1.71M Buy
21,142
+1,334
+7% +$104K 0.48% 40
2023
Q3
$1.48M Buy
19,808
+1,774
+10% +$136K 0.48% 40
2023
Q2
$1.39M Buy
+18,034
New +$1.44M 0.49% 38
2022
Q4
Sell
-14,270
Closed -$880K 245
2022
Q3
$880K Buy
14,270
+1,018
+8% +$64.2K 0.54% 30
2022
Q2
$819K Buy
+13,252
New +$820K 0.51% 33

Other funds holding GILD

Wahed Invest's GILD Position: Q1 2026 in Review

Wahed Invest reduced its Gilead Sciences (GILD) stake by 3.9% in Q1 2026, selling an estimated $177K and leaving 31,533 shares worth $4.39M. The position accounts for 0.57% of the portfolio, ranked #32.

Wahed Invest first reported a position in GILD in Q2 2022 and has held it in 11 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Wahed Invest held 31,533 shares of Gilead Sciences worth $4.39M as of Q1 2026.
  • Wahed Invest sold 1,263 Gilead Sciences shares in Q1 2026, an estimated $177K.
  • Gilead Sciences made up 0.57% of Wahed Invest's portfolio in Q1 2026, its #32 holding.
  • Wahed Invest first reported a position in Gilead Sciences in Q2 2022 and has held it in 11 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Wahed Invest's 13F filing for Q1 2026, filed 13 May 2026.